Related Experiment Videos
Should your algorithm include plasma rich in growth factors in the light of its clinical efficacy and safety?: By
Olivier Bruyère1, Jean-Yves Reginster1, Cyrus Cooper2
1Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
Seminars in Arthritis and Rheumatism
|December 3, 2014
Abstract
No abstract available in PubMed .